Invitrogen Corporation Launches GIBCO(R) AlgiMatrix(TM) 3D Culture System

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, today announced the launch of the GIBCO® AlgiMatrix™ 3D culture system, an animal-origin free bioscaffold that more closely mimics the conditions of a cell in the human body. AlgiMatrix™ provides superior cell loading, nutrient delivery and potential for cell-to-cell interaction.

MORE ON THIS TOPIC